PI3K/AKT/mTORC1 and MEK/ERK signaling in T-cell acute lymphoblastic leukemia: New options for targeted therapy

Alberto M. Martelli; Giovanna Tabellini; Francesca Ricci; Camilla Evangelisti; Francesca Chiarini; Roberta Bortul; James A. McCubrey; Francesco Antonio Manzoli

doi:10.1016/j.advenzreg.2011.09.019

PI3K/AKT/mTORC1 and MEK/ERK signaling in T-cell acute lymphoblastic leukemia: New options for targeted therapy

Alberto M. Martelli, Giovanna Tabellini, Francesca Ricci, Camilla Evangelisti, Francesca Chiarini, Roberta Bortul, James A. McCubrey, Francesco Antonio Manzoli

Istituti Ortopedici Rizzoli

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	214-227
Number of pages	14
Journal	Advances in Biological Regulation
Volume	52
Issue number	1
DOIs	https://doi.org/10.1016/j.advenzreg.2011.09.019
Publication status	Published - Jan 2012

ASJC Scopus subject areas

Cancer Research
Genetics
Molecular Biology
Molecular Medicine

Access to Document

10.1016/j.advenzreg.2011.09.019

Cite this

PI3K/AKT/mTORC1 and MEK/ERK signaling in T-cell acute lymphoblastic leukemia : New options for targeted therapy. / Martelli, Alberto M.; Tabellini, Giovanna; Ricci, Francesca; Evangelisti, Camilla ; Chiarini, Francesca; Bortul, Roberta; McCubrey, James A.; Manzoli, Francesco Antonio.

In: Advances in Biological Regulation, Vol. 52, No. 1, 01.2012, p. 214-227.

Research output: Contribution to journal › Article › peer-review

@article{aaa34d17e2e24a7087131b6803df0483,

title = "PI3K/AKT/mTORC1 and MEK/ERK signaling in T-cell acute lymphoblastic leukemia: New options for targeted therapy",

author = "Martelli, {Alberto M.} and Giovanna Tabellini and Francesca Ricci and Camilla Evangelisti and Francesca Chiarini and Roberta Bortul and McCubrey, {James A.} and Manzoli, {Francesco Antonio}",

year = "2012",

month = jan,

doi = "10.1016/j.advenzreg.2011.09.019",

language = "English",

volume = "52",

pages = "214--227",

journal = "Advances in Biological Regulation",

issn = "2212-4926",

publisher = "Elsevier BV",

number = "1",

}

TY - JOUR

T1 - PI3K/AKT/mTORC1 and MEK/ERK signaling in T-cell acute lymphoblastic leukemia

T2 - New options for targeted therapy

AU - Martelli, Alberto M.

AU - Tabellini, Giovanna

AU - Ricci, Francesca

AU - Evangelisti, Camilla

AU - Chiarini, Francesca

AU - Bortul, Roberta

AU - McCubrey, James A.

AU - Manzoli, Francesco Antonio

PY - 2012/1

Y1 - 2012/1

UR - http://www.scopus.com/inward/record.url?scp=84865634004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865634004&partnerID=8YFLogxK

U2 - 10.1016/j.advenzreg.2011.09.019

DO - 10.1016/j.advenzreg.2011.09.019

M3 - Article

C2 - 21983557

AN - SCOPUS:84865634004

VL - 52

SP - 214

EP - 227

JO - Advances in Biological Regulation

JF - Advances in Biological Regulation

SN - 2212-4926

IS - 1

ER -

PI3K/AKT/mTORC1 and MEK/ERK signaling in T-cell acute lymphoblastic leukemia: New options for targeted therapy

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this